SBIR/STTR Research Award
IMMUNODIRECTABLE MR CONTRAST AGENTS
Award amount
$50,000Program and phase
SBIR · Phase IAward year
1987Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- ADVANCED MAGNETICS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
A NUMBER OF SYNTHESES OF SMALL MAGNETIC PARTICLES PERMITTINGTHE COVALENT ATTACHMENT OF ANTIBODIES WILL BE EXAMINED. CHANGES IN MAGNETIC RESONANCE (MR) PROTON RELAXATION AFTER MAGNETIC ANTIBODIES HAVE BOUND TO CELL SURFACE ANTIGENS WILLBE UTILIZED TO DEMONSTRATE THE BINDING OF ANTIBODY (AND MAGNETIC LABEL) TO ANTIGENS. THE MAGNETIC LABELS INVESTIGATED WILL POSESS THE MAGNETIC PROPERTIES OF A CRYSTAL (E.G., HIGH MAGNETIC SUSCEPTIBILITY)AND THE SOLUTION PROPERTIES OF SOLUBLE MACROMOLECULES (E.G.,NO SETTLING ON PROLONGED STANDING). ONE ADVANTAGE OF ATTACHING ANTIBODY TO MAGNETIC PARTICLES, OVER THE OFTEN-USED APPROACH OF DERIVATIZING PROTEINS WITH CHELATORS,IS THAT FAR MORE METAL IONS CAN BE ATTACHED PER MOLE OF ANTIBODY. IN ADDITION, UNLIKE RADIOLABELED ANTIBODIES, MAGNETIC LABELS SHOW NO RADIOACTIVE DECAY. HIGHLY MAGNETIC PROTEINS MAY BE USEFUL AGENTS FOR IMMUNODIRECTABLE MR CONTRAST AGENTS.
Technology keywords
Not reported